NASDAQ: SYSo Young International Inc Stock
$1.10-0.07 (-5.98%)
Updated Apr 15, 2024
SY Price
$1.10
Fair Value Price
N/A
Market Cap
$107.85M
52 Week Low
$0.83
52 Week High
$2.98
P/E
37.93x
P/B
0.32x
P/S
0.62x
PEG
N/A
Dividend Yield
5.45%
Revenue
$208.06M
Earnings
$3.00M
Gross Margin
63.7%
Operating Margin
0.21%
Profit Margin
1.4%
Debt to Equity
0.27
Operating Cash Flow
N/A
Beta
0.91
Next Earnings
May 20, 2024
Ex-Dividend
N/A
Next Dividend
N/A
SY Overview
So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments in the People's Republic of China and internationally. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment; equipment production, sales, and agency services; and micro finance services. As of December 31, 2021, it had approximately 8,400 medical aesthetic service providers and 5,000 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SY scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SY was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SY is good value based on its earnings relative to its share price (37.93x), compared to the US market average (41.94x)
P/E vs Market Valuation
SY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more SY due diligence checks available for Premium users.
Be the first to know about important SY news, forecast changes, insider trades & much more!
SY News
Valuation
SY fair value
Fair Value of SY stock based on Discounted Cash Flow (DCF)
Price
$1.10
Fair Value
$6.97
Undervalued by
84.21%
SY was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
37.93x
Industry
76.4x
Market
41.94x
SY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SY is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.32x
Industry
3.43x
SY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SY's financial health
Profit margin
Revenue
$55.1M
Net Income
$2.5M
Profit Margin
4.5%
SY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$453.4M
Liabilities
$92.1M
Debt to equity
0.27
SY's short-term assets ($239.16M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SY's short-term assets ($239.16M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
SY vs Health Information Service Stocks
So Young International Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.